COM:BICYCLETHERAPEUTICS
Bicycle Therapeutics
- Stock
Last Close
20.26
22/11 21:00
Market Cap
895.71M
Beta: -
Volume Today
284.35K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
net income | -16.26M - | -21.85M 34.36% | -30.61M 40.11% | -51.01M 66.66% | -66.82M 30.99% | -112.72M 68.69% | -180.66M 60.28% | |
depreciation and amortization | 332K - | 712K 114.46% | 960K 34.83% | 1.28M 33.02% | 1.41M 10.34% | 3.69M 161.82% | 6.55M 77.45% | |
deferred income tax | 119K - | -673K - | -1.67M 147.85% | -4.98M 198.32% | 3.31M 166.44% | |||
stock based compensation | 515K - | 1.02M 98.64% | 3.08M 201.37% | 6.51M 111.29% | 12.08M 85.49% | 26.78M 121.63% | 32.48M 21.28% | |
change in working capital | 13.02M - | -6.63M 150.93% | -7.43M 12.02% | 25.35M 441.26% | 38.06M 50.15% | 672K 98.23% | 76.66M 11,308.18% | |
accounts receivables | -400K - | 4.91M 1,327.25% | -2.15M 143.78% | 4.54M 311.40% | -1.64M 136.12% | 2.48M 251.25% | ||
inventory | -2.12M - | -2.55M 20.70% | 4.16M 263.00% | -4.79M 215.09% | -2.77M - | |||
accounts payables | 67K - | -169K 352.24% | 220K 230.18% | -663K 401.36% | 1.20M 280.39% | 2.56M 114.13% | 8.00M 212.46% | |
other working capital | 12.96M - | -3.95M 130.47% | -10.00M 153.46% | 24.00M 339.91% | 37.12M 54.65% | -248K 100.67% | 68.95M 27,902.82% | |
other non cash items | 856K - | 665K 22.31% | 5.38M 709.17% | 751K 86.04% | 2.14M 184.42% | 442K 79.31% | 1.04M 136.20% | |
net cash provided by operating activities | -1.42M - | -26.08M 1,742.97% | -28.61M 9.72% | -17.79M 37.83% | -14.79M 16.84% | -86.11M 482.07% | -60.63M 29.59% | |
investments in property plant and equipment | -1.11M - | -1.19M 6.56% | -1.55M 31.11% | -1.20M 22.83% | -2.03M 69.17% | -18.99M 835.32% | -2.93M 84.57% | |
acquisitions net | ||||||||
purchases of investments | ||||||||
sales maturities of investments | ||||||||
other investing activites | ||||||||
net cash used for investing activites | -1.11M - | -1.19M 6.56% | -1.55M 31.11% | -1.20M 22.83% | -2.03M 69.17% | -18.99M 835.32% | -2.93M 84.57% | |
debt repayment | -14.54M - | -15.00M 3.16% | ||||||
common stock issued | 1K - | 56.96M 5,695,600% | 48.14M 15.47% | 298.54M 520.10% | 5.70M 98.09% | 249.34M 4,272.17% | ||
common stock repurchased | ||||||||
dividends paid | ||||||||
other financing activites | 57.88M - | 25.43M 56.06% | 1.48M 94.17% | 29.24M 1,871.56% | 37.18M 27.17% | 989K 97.34% | 682K 31.04% | |
net cash used provided by financing activities | 57.88M - | 25.43M 56.06% | 58.44M 129.81% | 62.84M 7.53% | 320.73M 410.36% | 6.69M 97.91% | 250.03M 3,636.21% | |
effect of forex changes on cash | 2.91M - | -2.45M 184.07% | 465K 118.99% | 19K 95.91% | -1.21M 6,473.68% | -1.12M 7.51% | 1.35M 220.18% | |
net change in cash | 58.26M - | -4.28M 107.35% | 28.74M 770.95% | 43.87M 52.67% | 302.69M 589.92% | -99.53M 132.88% | 187.82M 288.71% | |
cash at beginning of period | 9.40M - | 67.66M 619.67% | 63.38M 6.33% | 92.12M 45.34% | 135.99M 47.63% | 438.68M 222.58% | 339.15M 22.69% | |
cash at end of period | 67.66M - | 63.38M 6.33% | 92.12M 45.34% | 135.99M 47.63% | 438.68M 222.58% | 339.15M 22.69% | 526.97M 55.38% | |
operating cash flow | -1.42M - | -26.08M 1,742.97% | -28.61M 9.72% | -17.79M 37.83% | -14.79M 16.84% | -86.11M 482.07% | -60.63M 29.59% | |
capital expenditure | -1.11M - | -1.19M 6.56% | -1.55M 31.11% | -1.20M 22.83% | -2.03M 69.17% | -18.99M 835.32% | -2.93M 84.57% | |
free cash flow | -2.53M - | -27.26M 978.48% | -30.17M 10.65% | -18.99M 37.06% | -16.82M 11.40% | -105.10M 524.69% | -63.56M 39.53% |
All numbers in USD (except ratios and percentages)